Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilgen Mender

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Role of tankyrase scaffolding in the β-catenin destruction complex and WNT signalingQian Wang, Liping Li, Lin You, et al.
Molecular Cancer Therapeutics|April 18, 2023
Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular CarcinomaIlgen Mender, Silvia Siteni, Summer Barron, et al.
Nature Communications|January 22, 2024
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancerBuse Eglenen-Polat, Ryan R Kowash, Hai-Cheng Huang, et al.
Neoplasia (New York, N.Y.)|July 18, 2018
Telomerase-Mediated Strategy for Overcoming Non-Small Cell Lung Cancer Targeted Therapy and Chemotherapy ResistanceIlgen Mender, Ryan LaRanger, Krishna Luitel, et al.
Nature Communications|May 20, 2024
Tryptophan fuels MYC-dependent liver tumorigenesis through indole 3-pyruvate synthesisNiranjan Venkateswaran, Roy Garcia, M Carmen Lafita-Navarro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2021
A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in GliomasShengnan Yu, Shiyou Wei, Milan Savani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2018
Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant MelanomaGao Zhang, Lawrence W Wu, Ilgen Mender, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Role of tankyrase scaffolding in the β-catenin destruction complex and WNT signalingQian Wang, Liping Li, Lin You, et al.
Molecular Cancer Therapeutics|April 18, 2023
Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular CarcinomaIlgen Mender, Silvia Siteni, Summer Barron, et al.
Nature Communications|January 22, 2024
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancerBuse Eglenen-Polat, Ryan R Kowash, Hai-Cheng Huang, et al.
Neoplasia (New York, N.Y.)|July 18, 2018
Telomerase-Mediated Strategy for Overcoming Non-Small Cell Lung Cancer Targeted Therapy and Chemotherapy ResistanceIlgen Mender, Ryan LaRanger, Krishna Luitel, et al.
Nature Communications|May 20, 2024
Tryptophan fuels MYC-dependent liver tumorigenesis through indole 3-pyruvate synthesisNiranjan Venkateswaran, Roy Garcia, M Carmen Lafita-Navarro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2021
A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in GliomasShengnan Yu, Shiyou Wei, Milan Savani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2018
Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant MelanomaGao Zhang, Lawrence W Wu, Ilgen Mender, et al.
Pageof 3